8-KLeadership Changes

THERMO FISHER SCIENTIFIC INC. 8-K Report, Executive Changes (Jul 13, 2023)

Filed July 13, 2023For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) announced a change to its Board of Directors. Effective July 13, 2023, the Board's size was increased to twelve members with the appointment of Jennifer “Jenny” Johnson as a new director. Ms. Johnson brings extensive leadership experience, currently serving as President and CEO of Franklin Resources, Inc., a global asset manager with over $1.4 trillion in assets under management, and has a 35-year career at the company. Her appointment is expected to add valuable insights to Thermo Fisher's board, given her deep experience across various facets of a large financial services organization. Ms. Johnson will serve a term expiring at the Company's 2024 annual meeting and will be compensated according to the company's standard arrangements for non-employee directors. The board has not yet assigned her to any committees.

Key Highlights

  • 1Thermo Fisher Scientific Inc. has appointed Jennifer “Jenny” Johnson as a new director to its Board.
  • 2The Board size has been increased to twelve members to accommodate the new appointment.
  • 3Ms. Johnson is the President and CEO of Franklin Resources, Inc. (Franklin Templeton).
  • 4She possesses 35 years of experience at Franklin Templeton, holding leadership roles across key divisions.
  • 5Ms. Johnson's appointment is effective July 13, 2023, and her term expires at the 2024 annual meeting.
  • 6She will receive standard compensation for non-employee directors and enter into an indemnification agreement.
  • 7No committee assignments for Ms. Johnson have been announced at this time.

Frequently Asked Questions

Jennifer “Jenny” Johnson is the President and CEO of Franklin Resources, Inc. (Franklin Templeton) and has a 35-year career with the company. She is joining Thermo Fisher Scientific's Board of Directors to bring her extensive leadership experience in the financial services industry and asset management to the company's strategic oversight.

Ms. Johnson's appointment is intended to enhance the expertise and diversity of the Board. Her significant experience in leading a large global asset manager could provide valuable strategic insights into areas such as financial operations, technology adoption, and overall business transformation, which may benefit Thermo Fisher Scientific's growth and operational strategies.

Ms. Johnson will be compensated in accordance with Thermo Fisher Scientific's standard agreements and arrangements for non-employee directors. She will also enter into the company's standard form of indemnification agreement to protect her in her directorial capacity.

No, at the time of this filing, the Board has not yet appointed Ms. Johnson to any Board committees.